Cargando…
Individualized prediction of survival benefit from postoperative radiotherapy for patients with malignant pleural mesothelioma
OBJECTIVES: The role of postoperative radiotherapy (PORT) in malignant pleural mesothelioma (MPM) remains controversial and the eighth edition TNM staging scheme for MPM has not been fully verified. We aimed to develop an individualized prediction model for identifying optimal candidates for PORT am...
Autores principales: | Wo, Yang, Peng, Yizhou, Wu, Zhigang, Liu, Pengcheng, Shang, Yan, Shen, Xuxia, Sun, Yihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278470/ https://www.ncbi.nlm.nih.gov/pubmed/37076977 http://dx.doi.org/10.1002/cam4.5955 |
Ejemplares similares
-
Survival benefit after radiotherapy for patients with malignant pleural mesothelioma: A propensity score‐matched study
por: Lian, Liyou, et al.
Publicado: (2023) -
Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009) -
GOECP/SEOR clinical guidelines on radiotherapy for malignant pleural mesothelioma
por: Luna, Javier, et al.
Publicado: (2021) -
Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma
por: Al Khatib, MHD Ouis, et al.
Publicado: (2023) -
Clinical outcome of postoperative highly conformal versus 3D conformal radiotherapy in patients with malignant pleural mesothelioma
por: Krayenbuehl, Jérôme, et al.
Publicado: (2014)